Our Facilities

Both CDMO facilities in Poland and Portugal are cGMP compliant for the development and production of cell therapy products for clinical trial use and commercial production.

Warsaw

Our 1,100-square meter facility contains over 600 square meters of GMP production space. We have 16 separate production suites split into tissue-engineered and somatic cell therapy products, as well as gene modified products. We can produce treatments tailored for individual patients (autologous) or for larger groups (allogeneic) to support research and clinical trials. We also provide the necessary documentation to simplify the approval process with regulators. The GMP suite design includes class B clean rooms equipped with class A cabinets. Our facility is capable of producing a wide range of cell therapies using different types of cells, customized to meet the specific needs of our clients.

Cantanhede

With a total area of 900 square meters the Cantanhede facility operates as a fully integrated cell and tissue processing facility, including a GMP area for the manufacturing of investigational cell-based therapy products. The GMP area includes 3 class B rooms, and it is designed to handle multi-product manufacturing. The state-of-the-art quality control laboratory also operates under GMP compliance and the team has long track record of analytical methods development and validation for cell therapy products, including flow cytometer, molecular biology, endotoxins and microbiological analyses. The facility also includes a cryopreservation storage area compliant with both GMP and GDP (Good Distribution Practices).

Our Facilities

Our Facilities

Warsaw

Cantanhede